Pharmacotherapy for critical limb ischaemia (Q34071996)

30 July 2017

1 reference

title

Pharmacotherapy for critical limb ischaemia (English)

1 reference

30 July 2017

0 references

Norgren L

1

1 reference

30 July 2017

publication date

1 September 2000

1 reference

Diabetes - Metabolism: Research and Reviews

30 July 2017

published in

1 reference

30 July 2017

volume

16 Suppl 1

1 reference

30 July 2017

page(s)

S37-41

1 reference

A decade of oral anticoagulant treatment to maintain autologous vein grafts for femoropopliteal atherosclerosis.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR108%3E3.0.CO%3B2-E

Defibrinogenation treatment in patients suffering from severe intermittent claudication - a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR108%3E3.0.CO%3B2-E

Treatment of severe foot ischaemia by defibrination with ancrod: A randomized blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR108%3E3.0.CO%3B2-E

A stable prostacyclin analogue (iloprost) in the treatment of ischaemic ulcers of the lower limb. A Scandinavian-Polish placebo controlled, randomised multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR108%3E3.0.CO%3B2-E

Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR108%3E3.0.CO%3B2-E

Lumbar sympathectomy for arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR108%3E3.0.CO%3B2-E

Direct evidence of active sympathetic vasodilatation in the skin of the human foot

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR108%3E3.0.CO%3B2-E

Chelation therapy for peripheral arterial occlusive disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR108%3E3.0.CO%3B2-E

Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR108%3E3.0.CO%3B2-E

Adjuvant prostanoid treatment during femorodistal reconstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR108%3E3.0.CO%3B2-E

Intracoronary stenting without coumadin: one month results of a French multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR108%3E3.0.CO%3B2-E

Results of a Prospective Randomized Trial Evaluating Surgery Versus Thrombolysis for Ischemia of the Lower Extremity The STILE Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR108%3E3.0.CO%3B2-E

Effects of perioperative iloprost on patency of femorodistal bypass grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR108%3E3.0.CO%3B2-E

Naftidrofuryl for ischaemic rest pain: a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR108%3E3.0.CO%3B2-E

Comparative effects of some calcium-channel blockers on human peripheral arteries and veins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR108%3E3.0.CO%3B2-E

Clinical use of calcium antagonists in peripheral circulatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR108%3E3.0.CO%3B2-E

The effects of nifedipine on blood flow in peripheral vascular disease of the lower limbs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR108%3E3.0.CO%3B2-E

[Iloprost, a stable prostacyclin derivative, in stage 4 arterial occlusive disease. A placebo-controlled multicenter study]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR108%3E3.0.CO%3B2-E

A prospective randomized trial of aspirin in femoral popliteal and tibial bypass grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR108%3E3.0.CO%3B2-E

The efficacy of dextran 40 in preventing early postoperative thrombosis following difficult lower extremity bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR108%3E3.0.CO%3B2-E

Low molecular mass heparin instead of unfractionated heparin during infrainguinal bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR108%3E3.0.CO%3B2-E

Influence of coumarin treatment on patency and limb salvage after peripheral arterial reconstructive surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR108%3E3.0.CO%3B2-E

Platelet inhibition with ASA/dipyridamole after percutaneous balloon angioplasty in patients with symptomatic lower limb arterial disease. A prospective double-blind trial. Study group on pharmacological treatment after PTA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-7560%28200009%2F10%2916%3A1%2B%3C%3A%3AAID-DMRR108%3E3.0.CO%3B2-E

10.1002/1520-7560(200009/10)16:1+<::AID-DMRR108>3.0.CO;2-E

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference